CLINICAL_TRIALS
trial_result
· 2012-08-17
Clinical Trial Update: A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM) [Phase 2]
Summary
Phase 2 pharmacokinetic-pharmacodynamic study evaluating PSN821 in adults with Type 2 Diabetes Mellitus. The trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prosidion Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED